Compare JetBlue Airways Corporation (JBLU) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JetBlue Airways Corporation vs Smith & Nephew plc — how do they compare? JetBlue Airways Corporation trades at $3.85 (market cap $1.48B), while Smith & Nephew plc trades at $27.21 (market cap $11.10B). The key difference: Smith & Nephew plc is far larger — about 7.5× JetBlue Airways Corporation's market cap, and Smith & Nephew plc pays a 2.95% dividend while JetBlue Airways Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold JetBlue Airways Corporation for 44 Days and Smith & Nephew plc for 121 Days on average.
| JBLU | SNN | |
|---|---|---|
Market Cap | $1.48B | $11.10B |
Volume | 30,275,693 | 1,051,703 |
Sector | Industrials | Health |
52-Week High | $6.46 | $37.17 |
52-Week Low | $3.92 | $26.42 |
Typical Hold Time | 44 Days | 121 Days |
Enterprise Value | $8.84B | $14.13B |
Dividend Yield | — | 2.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JetBlue (JBLU) trades at $3.84, down 3.27% today, reflecting ongoing challenges in the airline sector. The stock shows bearish technical signals with negative moving averages and oscillators. Fundamentally, JBLU reported a net loss of $602 million in 2025 with negative profit margins, though revenue remains stable at $9.06 billion. Recent developments include route expansion to Colombia and the launch of BlueFirst premium seating, while activist investor Carl Icahn recently reduced board representation.
The outlook remains challenging with elevated fuel costs and competitive pressures. While the stock trades below book value (P/B 0.93) and analyst consensus target of $5.89, persistent losses and high debt levels pose significant risks. Institutional buying by Bank of America provides some support, but profitability improvement is essential for sustained recovery.
Smith+Nephew (SNN) trades at $27.24, near its 52-week low of $27.05, with a bearish technical signal despite recent earnings beats. Revenue grew to $6.16B in 2025, with net income margin improving to 10.08%, but the stock faces headwinds from analyst downgrades and CFO departure news. Product launches like the EVOS PELVIC System highlight innovation, yet investor sentiment remains cautious.
The outlook is mixed: strong fundamentals and undervaluation (P/E 18.34) offer upside, but technical weakness and competitive risks temper near-term gains. Key risks include execution challenges and market volatility, while institutional interest (e.g., BlackRock's $505M stake) provides support. Investors should weigh solid profitability against sentiment-driven price pressure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
